Biotech

Senior Biotech recruitment is its own discipline, because biotech leadership is unlike any other. The founding scientist who conceives a therapy is rarely the chief executive who scales the company, and the leader who thrives in a global pharmaceutical group may struggle in a business of forty people burning investor capital against a clinical milestone. Our consultants work closely with biotechnology companies and their investors across the UK, particularly in the golden triangle of Cambridge, Oxford and London where much of Europe’s biotech is built. This is specialist life sciences recruitment at the sharp end, part of our wider life sciences practice, applied to the appointments investors and boards care about most.

Biotech leaders we appoint

Most of our assignments in this sector sit at board and executive level, where a single appointment can determine whether a company reaches its next milestone or its next funding round. We appoint across the leadership team of science-led businesses, from the executives who set direction to the leaders who deliver the science.

• Chief executives and managing directors leading biotech companies from seed stage to listing, supported by our board level practice
• Chief scientific officers and heads of research who own the science and the platform
• Chief medical officers and development leaders who design and run clinical programmes
• Chief financial and business officers who raise capital and strike the partnering deals
• Operations, manufacturing and quality leaders who industrialise the science, including CMC and biologics manufacturing

Areas we cover

Biotechnology is not a single market, and the right leader for a cell therapy company is rarely the obvious appointment in diagnostics or industrial biotech. Stone Executive recruits across the full range of modalities and business models, matching each search to consultants who understand that specific science and its investors.

• Therapeutics: small molecule, biologics & vaccines
• Cell & gene therapy
• Platform technologies & drug discovery (including AI-led)
• Diagnostics & genomics
• Industrial & agricultural biotech
• CDMO, bioprocessing & manufacturing

This is the biotechnology market from start-up to scale. Where a company matures towards commercial launch our pharmaceutical practice works alongside us, and for device and digital businesses our medical device practice leads, so the right leader is appointed to the right remit.

What is changing in Biotech leadership

Biotechnology is being reshaped, and the appointments companies make now reflect it. Artificial intelligence is changing how drugs are discovered, cell and gene therapies have created entirely new manufacturing and regulatory challenges, and a tighter funding environment has made investors more demanding about the leadership teams they back. Boards and investors have raised the bar on biotech leadership accordingly.

We see it in every mandate. Where companies once wanted scientific brilliance above all, they now look for leaders who can pair it with capital discipline, credible development plans and the ability to partner with big pharma from a position of strength. The companies that appoint that blend are the ones that survive the funding cycle and reach their milestones.

Why specialist Biotech search matters

In biotech, an appointment can look inspired on announcement day and prove wrong within a funding cycle. A distinguished academic does not always make a chief scientific officer, and a big-pharma executive is not necessarily suited to a company where the entire strategy can turn on one data readout. A search that screens for pedigree rather than the fit with the company’s stage, science and investors is the usual reason a senior appointment disappoints, and at this level the cost is measured in missed milestones and lost funding, not simply salary.

Avoiding that outcome takes market knowledge, not process. Our consultants know the life sciences market well enough to weigh what a candidate actually contributed to past programmes and raises, and they apply that scrutiny from the first briefing, so the shortlist that reaches the board has already survived it. It is the same research-led discipline that runs through all of our wider executive search work.

Our Biotech search process

A Biotech search with us moves through four stages, calibrated to the company’s stage and runway. A named consultant leads the engagement from first conversation to appointment, supported by our in-house research team, and the four stages below move in order, with timing shaped by the funding clock and the discretion the search requires.

Understanding the role. We begin with the chief executive, board or investors who own the appointment, building a clear picture of the science, the development stage, the funding position, the culture, and what the right person needs to achieve. For a CEO or CSO appointment, that includes a candid conversation about how the company’s story will land with the candidates strong enough to lead it.

Mapping the market. Drawing on our network and structured research, we identify the biotech leaders who genuinely fit, across competitor companies, big pharma and academia where the right experience can be found. Senior moves in a small, well-connected community are sensitive, so this stage is handled with particular discretion.

Approaching candidates. The leaders biotech boards want are mid-programme, funded and courted constantly; no advertisement reaches them. What does is a discreet approach from a consultant who can speak credibly about the science, the investors and why this role deserves their attention.

Shortlist to appointment. The outcome is a short, rigorously argued list of candidates, each profiled in writing: scientific and commercial substance, leadership history, and our honest view of their fit. From there we manage the process through interviews and any assessment required, and on to offer and acceptance.

FAQs

To discuss a chief executive, chief scientific officer, or senior biotech appointment, please contact our team on 0333 800 1560.